Experimental Study of the Effectiveness of Phenolic Antioxidants in Male Infertility Caused by Pathospermia


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The effect of phenolic antioxidants (dihydroquercetin, p-tyrosol, dibornol) on the morphology, functions, and redox processes in the reproductive cells of male rats was studied on the model of experimental pathospermia. All antioxidants reduced the percentage of degenerative forms of spermatozoa. Dibornol was most effective. Dihydroquercetin and p-tyrosol did not increase the total number of spermatozoa and the percentage of their mobile forms. These indicators were improved only by dibornol. After administration of all test drugs, the antioxidant potential of spermatozoa increased and did not significantly differ from the baseline values.

Sobre autores

T. Borovskaya

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Autor responsável pela correspondência
Email: repropharm@yandex.ru
Rússia, Tomsk

S. Kamalova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Tomsk

N. Krivova

Research Institute of Biology and Biophysics, National Research Tomsk State University

Email: repropharm@yandex.ru
Rússia, Tomsk

O. Zaeva

Research Institute of Biology and Biophysics, National Research Tomsk State University

Email: repropharm@yandex.ru
Rússia, Tomsk

M. Poluektova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Tomsk

A. Vychuzhanina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Tomsk

V. Grigor’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Tomsk

M. Plotnikov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Tomsk

V. Goldberg

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Tomsk

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018